| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |